[fullwidth background_color=”” background_image=”” background_parallax=”none” enable_mobile=”no” parallax_speed=”0.3″ background_repeat=”no-repeat” background_position=”left top” video_url=”” video_aspect_ratio=”16:9″ video_webm=”” video_mp4=”” video_ogv=”” video_preview_image=”” overlay_color=”” overlay_opacity=”0.5″ video_mute=”yes” video_loop=”yes” fade=”no” border_size=”0px” border_color=”” border_style=”” padding_top=”20″ padding_bottom=”20″ padding_left=”0″ padding_right=”0″ hundred_percent=”no” equal_height_columns=”no” hide_on_mobile=”no” menu_anchor=”” class=”” id=””][title size=”1″ content_align=”left” style_type=”underline solid” sep_color=”#000000″ margin_top=”” margin_bottom=”” class=”” id=””]Monsanto announces that it will assemble a panel of scientists to review the IARC analysis[/title][fusion_text]Wednesday, July 15th 2015
Monsanto announced Tuesday that it will assemble a panel of scientists to review the International Agency for Research on Cancer’s (IARC) analysis that led to the classification of the herbicide glyphosate as “probably carcinogenic” to humans. That classification by IARC, an arm of the World Health Organization, in March sparked a fierce rebuttal from the agricultural science community. Monsanto introduced the widely-used glyphosate herbicide Roundup in 1974. The full monograph, which details how IARC reached its decision, is expected to be released this month. In the U.S. Environmental Protection Agency’s review of glyphosate, the EPA concluded the herbicide does not pose a risk to human health if used according to instructions on the label. The German Risk Agency (BfR) is conducting a glyphosate registration review that began in 2012 for the European Union. In an update on the investigation released in January, it said the review “did not provide any indications that glyphosate has carcinogenic [effects].” Farmer said the Intertek panel will have ultimate control over its schedule, but should conclude its analysis within the next couple of months and will disclose its conclusions for public review.
[/fusion_text][/fullwidth]